Core Laboratories offers an attractive valuation and strong cash conversion, but declining revenue, a failed momentum gate, and justified elevated short interest reflect real near-term operating headwinds.
Thesis pillars
- Earnings Beat Streak Catalyst→Stable
- Attractive Valuation Strong Cash Conversion→Stable
- Declining Revenue And Failed Momentum↑Improving
- +2 more pillars — see the Why tab for full reasoning
Core Laboratories Inc. (CLB) Stock Analysis
Catalyst-Driven edge
Energy · Oil & Gas Equipment & Services
Hold if already holding. Not a fresh buy at $10.01, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Negative momentum.
We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major,... Read more
Hold if already holding. Not a fresh buy at $10.01, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Mixed signals. Hold existing position. Score 5.2/10, moderate confidence.
Passes 6/9 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 15d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.
Recent developments
updated 2026-10-13Recent Developments — Core Laboratories Inc.
Latest news
- NEWS Core Laboratories (NYSE:CLB) Issues Earnings Results - MarketBeat — MarketBeat neutral
- NEWS Core Laboratories (NYSE:CLB) Releases Q3 2026 Earnings Guidance - MarketBeat — MarketBeat neutral
- NEWS Core Laboratories (NYSE:CLB) Misses Q2 CY2026 Sales Expectations - StockStory — StockStory negative
- NEWS Is Core Laboratories Inc (CLB) Undervalued After Q2 Earnings Mis - GuruFocus — GuruFocus positive
- NEWS Core Laboratories Reports Mixed Q2 2026 Results, Boosts Liquidity - TipRanks — TipRanks neutral
Generated 2026-10-13T11:47:14Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-08-25Item 5.02MEDIUM(d) | | Exhibits 17.1 [Letter dated August 25, 2026 from Mr. Temeng to the Board of Directors of Core Laboratories Inc.](https://www.sec.gov/Archives/edgar/data/1958086/000119312526365271/clb-ex17_1.htm) 104 [... truncated]SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $10.01, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Mixed signals. Hold existing position. Target $12.75 (+27.4%), stop $9.34 (−7.2%), A.R:R 3.6:1. Score 5.2/10, moderate confidence.
Take-profit target: $12.75 (+27.4% upside). Target $12.75 (+27.4%), stop $9.34 (−7.2%), A.R:R 3.6:1. Stop-loss: $9.34.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Negative momentum; Below 200-MA, MA slope -4.6%/30d (confirmed downtrend).
Core Laboratories Inc. trades at a P/E of 19.3 (forward 14.5). TrendMatrix value score: 8.4/10. Verdict: Hold.
10 analysts cover CLB with a consensus score of 2.4/5. Average price target: $15.
What does Core Laboratories Inc. do?We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir...
We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major, national and independent oil companies. These services and products can enable our clients to evaluate and improve reservoir performance and increase oil and gas recovery from their new and existing fields.